HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The quiet carrier of beta-thalassemia.

Abstract
Heterozygosity for beta-thalassemia is usually characterized by hypochromia, microcytosis, mild anemia, and increased percentage of Hb A2, and normal or mildly increased Hb F. We have studied an unusual type of beta-thalassemia with typical morphologic abnormalities but normal levels of Hb A2 and Hb F, with diagnosis confirmed by globin synthesis studies. The results indicate that globin synthesis studies may be necessary when the cause of hypochromia and microcytosis cannot be clearly determined by hemoglobin quantitation and electrophoresis and other standard clinical tests.
AuthorsJ F Kelleher Jr, E Schwartz
JournalThe American journal of pediatric hematology/oncology (Am J Pediatr Hematol Oncol) Vol. 1 Issue 1 Pg. 15-7 ( 1979) ISSN: 0192-8562 [Print] United States
PMID543507 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Globins
  • Hemoglobin A2
Topics
  • Child, Preschool
  • Female
  • Globins (biosynthesis)
  • Hemoglobin A2 (analysis, biosynthesis)
  • Heterozygote
  • Humans
  • Thalassemia (diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: